Abstract:PPARγ, originally cloned as a transcription factor involved in fat cell differentiation, is activated by endogenous ligands, such as fatty acids produced by sterol response element binding protein 1 (SREBP1) and fatty acids synthase (FASN) pathways and synthetic ligands including the thiazolidinediones (TZD). PPARγ is expressed in a variety of cancer cells. Independent lines of evidence support a role for PPARγ to either inhibit or promote tumorigenesis. Human breast cancer is associated with ErbB2 amplification or overexpression in >30% of patients. Although PPARγ is reduced in ErbB2 induced tumor, the role of PPARγ in growth control of ErbB2-induced tumorigenesis is poorly understood. The addition of ligand activates the receptor by inducing a conformational change in the receptor, which can be recapitulated by mutation. To investigate the role of activated PPARγ signaling in breast cancer, we compared the function of a constitutively active PPARγ (PγCA) mutant with the wild-type PPARγ in ErbB2-induced mammary tumorigenesis in vivo. Tumor cells transduced with either PPARγ or PγCA were implanted into immune competent FVB mice. Enhanced tumor growth was observed in PγCA-transduced cells, which was associated with increased angiogenesis and endothelial stem cells as evidenced by increased number of cells stained with von Willebrand factor (vWF), c-Kit, CD133 and CD31. Genome-wide expression profiling identified a group of genes within the angiogenesis pathway, including Angptl4, as targets of activated PPARγ. PγCA also induced Angptl4 protein secretion in ErbB2-transformed mammary epithelial cells. Angptl4 promoted vascular endothelial cell migration and conversely immuno-depletion of Angptl4 reduced PγCA-mediated cellular migration. Collectively, these studies suggest that activated PPARγ induces Angptl4 to promote tumor growth through enhanced angiogenesis in vivo. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 1720.

Regulation of Retinoic Acid Receptor Beta Expression by Peroxisome Proliferator-Activated Receptor Gamma Ligands in Cancer Cells.

Regulation of Retinoic Acid Receptor Expression by Peroxisome Proliferator- activated Receptor Ligands in Cancer Cells1

Selective activation of PPARgamma in breast, colon, and lung cancer cell lines

Regulation Of Rar Beta Expression By Rar- And Rxr-Selective Retinoids In Human Lung Cancer Cell Lines: Effect On Growth Inhibition And Apoptosis Induction

Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids.

Pharmacological Exploitation of the Peroxisome Proliferator-Activated Receptor Gamma Agonist Ciglitazone to Develop a Novel Class of Androgen Receptor-Ablative Agents.

Retinoic Acid Nuclear Receptor Α (rarα), a Major Role in Mediating Retinoids Inhibition of Growth in Human Breast Carcinoma Cells

Pharmacological Exploitation of the Peroxisome Proliferator-Activated Receptor γ Agonist Ciglitazone To Develop a Novel Class of Androgen Receptor-Ablative Agents

Retinoid Receptors in Human Lung Cancer and Breast Cancer

Retinoid-resistant Estrogen Receptor-Negative Human Breast Carcinoma Cells Transfected with Retinoic Acid Receptor-Alpha Acquire Sensitivity to Growth Inhibition by Retinoids.

Identification of Retinoic Acid As an Inhibitor of Transcription Factor Nrf2 Through Activation of Retinoic Acid Receptor Alpha

Nicotine Modulates The Effects Of Retinoids On Growth Inhibition And Rar Beta Expression In Lung Cancer Cells

Oncogenic Potential Of Retinoic Acid Receptor-Gamma In Hepatocellular Carcinoma

Activation of peroxisome proliferator-activated receptor-β/δ (PPAR-β/δ) inhibits human breast cancer cell line tumorigenicity

Expression of Peroxisomal Proliferator-Activated Receptors and Retinoid X Receptors in the Kidney.

Effect of Ligand Activation of Peroxisome Proliferator-Activated Receptor-Β/δ (pparβ/δ) in Human Lung Cancer Cell Lines

Data from Activating Peroxisome Proliferator-Activated Receptor Γ Mutant Promotes Tumor Growth <i>in Vivo</i> by Enhancing Angiogenesis

[Retinoic Acid Nuclear Receptor Beta (RAR Beta) Inhibits Breast Carcinoma Growth].

Retinoic Acid Receptor Beta is Required for Anti-Activator Protein-1 Activity by Retinoic Acid in Gastric Cancer Cells.

[Mechanism of Retinoic Acid Receptor Alpha-Mediated Growth Inhibition of Gastric Cancer Cells by All-Trans Retinoic Acid].

Abstract 1720: Activating Peroxisome Proliferator-Activated Receptor Γ Mutant Promotes Tumor Growth in Vivo by Enhancing Angiogenesis